Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial

Abstract Introduction Contrast-induced acute kidney injury (CI-AKI) is known to be a complication of using intravascular contrast injection. Unfortunately, it is associated with adverse outcomes such as prolonged length of hospitalization and increased burden of health care costs. So, we aimed to de...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Nephrology
المؤلفون الرئيسيون: Iman Ibrahim Sarhan, Yasser A. Abdellatif, Rania Elsayed Saad, Nahla Mohamed Teama
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2023-03-01
الموضوعات:
الوصول للمادة أونلاين:https://doi.org/10.1186/s12882-023-03114-4

مواد مشابهة